Anavex Life Sciences Corp (AVXL)

[georgejjl]

Again, what do you think Dr. Missling meant when he said this

So for the Alzheimer’s study, do you think the primary completion date still stands at December of 2020? And then do you believe that you will need to conduct a second Phase 3 trial for FDA approval on the Alzheimer’s study?

Christopher Missling

So the expected date is provided in ClinicalTrials.gov and I think that’s what you’re referring to. That’s all the estimate which, we don’t provide or confirm. It is point in time. But obviously, we want to finish a study as soon as possible. As I mentioned today in all our studies, they all are with the aim of before or done undertaking to finish it as soon as possible. But the question is, so we will provide an update on the timing when we have more granularity on the overall continuous enrollment, which is very good so far. So I would basically not provide a comment on the timing of the end of that study yet. Regarding the question of if a second study is needed. That’s also a question I would defer to once we are able to share the data with the FDA, with the agency and that determination is done by the agency. So it’s not something which we can anticipate at this point.